On Tuesday, the national government authorized prepaid medicine companies to implement a bimonthly increase of up to 11.34% in their fees starting in August.
The measure was taken through resolution 1293/2022 of the Ministry of Health, which was published last Thursday in the Official Gazette.
The norm, which bears the signature of Minister Carla Vizzotti, approved the Health Cost Index, which contemplates the evolution of the items of human resources, medicines, medical supplies and other significant supplies.
According to the companies, this increase will allow “to face the successive increases in the costs of the prices of medicines and supplies, the parity of the health sector and new coverage”
By Resolution 867/2022, bimonthly increases had been authorized in April in the value of the quotas of the Prepaid Medicine Entities registered in the National Registry of Prepaid Medicine Entities (RNEMP) with a “maximum limit the variation of the Cost Index of Health”.
As of June 30, the calculation of this Index -which will be calculated again on the last day of August and October- showed a variation of 11.34%.
“This percentage represents the maximum proportion in which prepaid medicine entities may increase the quota values of their plans, being able to apply increases in a smaller proportion or not apply increases,” they clarified from the portfolio.
In the last few hours, the prepaid began sending notifications of changes in fees to their associates
In any case, before carrying out the increases that they define, the companies must inform the percentage of increase to be applied.
In the last hours, the prepaid began to send their partners notifications of changes in fees.
“In accordance with Resolution 1293/2022 of the Ministry of Health of the Nation and the publication made on the page of the Superintendency of Health Services, general, complementary and cumulative increases were arranged with respect to those previously authorized”, they affirmed from a of the main companies in the sector.
According to the companies, this increase will allow “to face the successive increases in the costs of the prices of medicines and supplies, the parity of the health sector and new coverage, as well as to continue maintaining the quality of service that we offer you.”
